Project Details
Description
MT2024-12: A Phase 1 Study Evaluating BAFFR-targeting CAR T cells for Patients with Relapsed or Refractory B-cell Non-Hodgkin s Lymphoma (B-NHL)
| Status | Active |
|---|---|
| Effective start/end date | 1/10/25 → 5/15/35 |
Funding
- PEPROMENE BIO, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.